How to Survive a DEA Inspection - Veterinary Medicine and Controlled Substances

This webinar will discuss federal laws on administering and dispensing veterinary medicine, penalties for non-compliance, DEA required records and effective methods to prevent unauthorized use of controlled substances.

Why Should You Attend:

The Drug Enforcement Administration (“DEA”) through their Office of Diversion Control (“Diversion”) is responsible for enforcing federal laws and DEA regulations pertaining to the administering, dispensing and prescribing of controlled substances by practitioners practicing veterinary medicine in a hospital, clinic or private office.

The Controlled Substances Act requires all veterinarian to maintain a complete and accurate records of any administering, dispensing or prescribing of Schedules II through V controlled substances used in treating animal patients.

Today’s practitioners, including veterinarians, need to take the necessary steps to prevent the theft and diversion of dispensed or prescribed medication and comply with federal or state laws and controlled regulations enforced by DEA and state regulatory entities pertaining to controlled substances.

Areas Covered in the Webinar:

1. Identify the role of DEA and the steps taken by DEA Diversion to enforce federal laws and regulations on registrants practicing veterinary medicine and administering, dispensing or prescribing Schedules II through V pharmaceutically made controlled substance.
2. Describe the types of administrative or civil actions that can be imposed by DEA and federal prosecutor’s office for failure to comply with federal laws and regulations pertaining to the administering, dispensing, and prescribing of controlled substances as part of veterinary medicine, surgery or dentistry and their animal patients.
3. Focus on DEA required records to include: DEA Forms 222 and invoices for receiving, returning or transferring controlled substances to a DEA registered reverse distributor for destruction. Other records include DEA biennial inventory, Power of Attorney forms to sign a DEA Form 222, submission of Theft or Loss Reports, etc.
4. Suggestions on effective methods to secure Schedules II to V controlled substances purchased for veterinary use and the handling of such substances to prevent the theft or loss that could reach the illicit market or harm humans or animals by its unauthorized use. The areas covered for security will include the use of CCTV and an alarm system for the office or vehicles use for house calls.

Who Will Benefit:

All medical practitioners whose field of medicine is veterinary medicine, surgery or dentistry and animal health technicians who are supervised by such practitioners.

• Veterinary medicine practitioners - physicians, surgeons, etc.
• Compliance officers in clinics and medical offices
• Pharmacists
• Manufacturers of veterinary medicine
• Distributors of veterinary medicine
• Veterinarians and animal health technicians

Note:

Use coupon code NB5SQH8N and get 10% off on registration.

For Registration:

http://www.complianceonline.com/dea-inspection-of-veterinary-medicine-and-controlled-substances-webinar-training-704885-prdw?channel=hum-molgen

Instructor Profile:

In January 2009, Carlos M. Aquino founded PharmaDiversion, LLC as a compliance consulting firm assisting DEA registrants, who handle controlled substances and regulated chemicals, with compliance of federal laws and regulations that are enforced by DEA through the Office of Diversion Control. This is done through a “Mock” audit and inspection equivalent to a DEA Diversion on-site inspection. The firm also provides in-service training on various areas pertaining to compliance with federal laws and DEA regulations for handling controlled substances.

Consultant Carlos M. Aquino brings 36 years of experience on handling illicit and pharmaceutical controlled substances and regulated chemicals. This includes 12 years with the Philadelphia DEA Diversion and 24 years with the Philadelphia Police Department. During the last 10 years, he was assigned to the Philadelphia DEA Task Force as a street supervisor, undercover agent and case agent investigating the distribution of illicit drugs and the diversion of pharmaceutical drugs.